Effects of the COVID‐19 pandemic on inpatient skin surgery in Germany: results of the DESSI‐survey

Abstract

SummaryBackgroundThe aim of the survey was to investigate a possible impairment of inpatient dermatological and dermatosurgical care in Germany due to the COVID‐19 pandemic.MethodsAn online survey on the impact of pandemic‐related measures on inpatient care was sent to all German dermatology clinics. Only one person per clinic was asked to participate. Data analysis was mainly descriptive. Differences between university hospitals and non‐university hospitals were calculated using the Chi‐square test.ResultsFrom the 113 dermatological clinics with inpatient care, we received 45 (39.8%) at least partially completed questionnaires. Of these, 25 (55.6%) came from university hospitals, 18 (40.0%) from teaching hospitals of a university, 1 (2.2%) from a non‐teaching hospital, and 1 (2.2%) from a participant who did not provide any information on his facility. More than half of survey participants (57.8%) reported that many elective skin surgeries had to be canceled at their clinics at the beginning of the COVID‐19 pandemic. However, most of the clinics (75.6%) were able to perform medically necessary surgeries (such as for malignant melanoma). Only 28.9% (13/45) of participants reported that skin surgery in their clinics returned to full strength after the COVID‐19 pandemic. There was no statistically significant difference between university hospitals and non‐university hospitals regarding the influence of COVID‐19‐related restrictions.ConclusionsDespite their heterogeneity, the results of the survey show an overall clear and long‐term pandemic‐related impairment of inpatient dermatology and skin surgery in Germany.